American Family Life Assurance Company of Columbus, Inc. is a life insurance company that provides voluntary insurance at worksites to individuals and businesses. The company offers individual policies, such as accident, cancer/specified-disease, critical care and recovery, dental, hospital confinement indemnity, hospital confinement sickness indemnity, hospital intensive care, juvenile life, life, lump sum cancer, lump sum critical illness, short-term disability, and vision insurance; and group products, which include critical illness, accident, hospital indemnity, disability, whole life, and dental insurance. It offers its solutions through brokers. The company was incorporated in 1955 and...
1932 Wynnton Road
Columbus, GA 31999-0001
Founded in 1955
American Family Life Assurance Company of Columbus Announces John Shelby Amos II to Assume as Market Director
Sep 29 14
On September 25, 2014, John Shelby Amos II notified Aflac Incorporated of his retirement as a director, effective October 1, 2014, to assume a salaried position of market director with American Family Life Assurance Company of Columbus. Previously, he served as a commission-based state sales coordinator. As part of a realignment of its U.S. sales operations, the Company previously announced the elimination of the commission-based position of state sales coordinator and the creation of the new position of market director. Mr. Amos had been contracted with Aflac as state sales coordinator since 1978. He will also serve as an emeritus director.
AFLAC U.S. Reports Financial Results for the First Quarter of 2013
Apr 24 13
AFLAC U.S. reported financial results for the first quarter of 2013. Total revenues increased 3.9% to $1.4 billion in the first quarter. Premium income increased 4.0% to $1.3 billion, and net investment income was up 3.4% to $157 million. The pretax operating profit margin decreased slightly from 19.6% a year ago to 19.5%. Pretax operating earnings were $281 million, an increase of 3.6% for the quarter. Aflac U.S. total new annualized premium sales decreased 5.2% to $332 million. Additionally, persistency in the quarter was 74.7%, which was unchanged from a year ago.